rs74349352

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000374.5(UROD):​c.*3G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 1,614,194 control chromosomes in the GnomAD database, including 127 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0087 ( 4 hom., cov: 32)
Exomes 𝑓: 0.011 ( 123 hom. )

Consequence

UROD
NM_000374.5 3_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: -1.01

Publications

4 publications found
Variant links:
Genes affected
UROD (HGNC:12591): (uroporphyrinogen decarboxylase) This gene encodes an enzyme in the heme biosynthetic pathway. This enzyme is responsible for catalyzing the conversion of uroporphyrinogen to coproporphyrinogen through the removal of four carboxymethyl side chains. Mutations and deficiency in this enzyme are known to cause familial porphyria cutanea tarda and hepatoerythropoetic porphyria.[provided by RefSeq, Aug 2010]
UROD Gene-Disease associations (from GenCC):
  • UROD-related inherited porphyria
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • familial porphyria cutanea tarda
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • hepatoerythropoietic porphyria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-45015501-G-A is Benign according to our data. Variant chr1-45015501-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 255960.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00874 (1331/152310) while in subpopulation NFE AF = 0.0127 (865/68024). AF 95% confidence interval is 0.012. There are 4 homozygotes in GnomAd4. There are 629 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,SD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
URODNM_000374.5 linkc.*3G>A 3_prime_UTR_variant Exon 10 of 10 ENST00000246337.9 NP_000365.3 P06132

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
URODENST00000246337.9 linkc.*3G>A 3_prime_UTR_variant Exon 10 of 10 1 NM_000374.5 ENSP00000246337.4 P06132

Frequencies

GnomAD3 genomes
AF:
0.00875
AC:
1331
AN:
152192
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00215
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0103
Gnomad ASJ
AF:
0.0144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00227
Gnomad FIN
AF:
0.0122
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0127
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00972
AC:
2445
AN:
251470
AF XY:
0.00978
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00766
Gnomad ASJ exome
AF:
0.0114
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0139
Gnomad NFE exome
AF:
0.0140
Gnomad OTH exome
AF:
0.0111
GnomAD4 exome
AF:
0.0115
AC:
16807
AN:
1461884
Hom.:
123
Cov.:
31
AF XY:
0.0113
AC XY:
8253
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00128
AC:
43
AN:
33480
American (AMR)
AF:
0.00731
AC:
327
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0116
AC:
304
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00292
AC:
252
AN:
86258
European-Finnish (FIN)
AF:
0.0133
AC:
713
AN:
53410
Middle Eastern (MID)
AF:
0.00589
AC:
34
AN:
5768
European-Non Finnish (NFE)
AF:
0.0130
AC:
14500
AN:
1112012
Other (OTH)
AF:
0.0105
AC:
632
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1003
2005
3008
4010
5013
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00874
AC:
1331
AN:
152310
Hom.:
4
Cov.:
32
AF XY:
0.00845
AC XY:
629
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00214
AC:
89
AN:
41558
American (AMR)
AF:
0.0103
AC:
158
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0144
AC:
50
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4834
European-Finnish (FIN)
AF:
0.0122
AC:
129
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0127
AC:
865
AN:
68024
Other (OTH)
AF:
0.0132
AC:
28
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
76
152
227
303
379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0111
Hom.:
8
Bravo
AF:
0.00852
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0131
EpiControl
AF:
0.0123

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 12, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, BP2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial porphyria cutanea tarda Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.040
DANN
Benign
0.79
PhyloP100
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74349352; hg19: chr1-45481173; API